Market News & Trends
Biomarkers Heavily Used as Diagnostic Tools in COVID-19 Trials
Biomarkers are a beneficial tool in the search for a COVID-19 vaccine and will help speed up clinical trials, reduce costs of development, guide subject…
Celsion Reports Sufficient Events Have Been Reached for the Second Interim Analysis of the Phase 3 OPTIMA Study
Celsion Corporation recently announced the prescribed minimum number of events of 158 patient deaths has been reached for the second pre-specified interim analysis of the…
7 Hills Pharma Announces COVID-19 Vaccine Program Targeting At-Risk Elderly
7 Hills Pharma, a clinical stage immunotherapy company focused on development of drugs for the treatment and prevention of cancer and infectious diseases, recently announced…
Vir Biotechnology Announces VIR-2218 Demonstrates Dose-Dependent & Durable Reductions of Hepatitis B Surface Antigen in Phase 1/2 Trial
Vir Biotechnology, Inc. recently announced additional interim data from the ongoing Phase 2 trial in patients and results from the Phase 1 trial in healthy…
Proveris to Present: The Effect of Ethanol Concentration on pMDI Evaporation Fraction
Proveris Scientific Corporation, a leading provider of services and technology to advance the science of spray and aerosol products, recently announced that on April 26…
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial
Precision BioSciences, Inc. recently announced the initiation of patient dosing in a Phase 1/2a clinical trial of its second off-the-shelf (allogeneic) chimeric….
OncoSec Collaborates With Providence Cancer Institute to Conduct First-in-Human Trial of Investigational Vaccine to Prevent COVID-19
OncoSec Medical Incorporated recently announced that Providence Cancer Institute, a part of Providence St. Joseph Health, is pursuing a first-in-human Phase 1 clinical trial of OncoSec’s novel….
Leading BioSciences Announces Potential for Investigational Drug to Treat Multiple Organ Dysfunction Syndrome in COVID-19 Patients
Leading BioSciences recently announced it has developed a potential approach to treat COVID-19 patients suffering from acute respiratory distress syndrome (ARDS) and multiple organ dysfunction syndrome (MODS) using its….
Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST Technology
SIRION Biotech GmbH recently announced that Beam Therapeutics licensed rights to use SIRION Biotech’s LentiBOOST for use in….
Cambrex Completes Biopharmaceutical Expansion at its Durham Facility
Cambrex recently announced it has completed an expansion of its biopharmaceutical analysis capabilities at the Durham, NC, site. Biopharmaceutical analysis services were initially launched at…
Roquette Launches Online Technical Platform for Researchers & Drug Developers
As virtual collaboration and knowledge-sharing have reached a new level of urgency within the scientific community, Roquette, a trusted global supplier to life science companies…
Cytovia Therapeutics & Macromoltek to Develop Dual-Acting Natural Killer Immunotherapy Against SARS CoV2 (COVID-19)
Cytovia Therapeutics recently announced it is expanding its programs to help urgently address the current SAR CoV2 (COVID-19) crisis. Natural Killer cells are a first…
Global Regulators Discuss Observational Studies of Real-World Data for COVID-19 Medicines
In a recent dedicated COVID-19 workshop, organized by the European Medicines Agency (EMA) under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA),…
Emisphere Announces Novo Nordisk Development Update
Novo Nordisk recently announced the European Commission (EC) has granted marketing authorization for Rybelsus, (oral semaglutide), for the treatment of adults with insufficiently controlled type…
Antiviral Drugs Market to Foresee Tremendous Gains Over 2020-2026
The global antiviral drugs market was valued at $56 billion in 2019 and is expected to accrue phenomenal gains over the forecast period. The spread…
Metrion Biosciences & International Scientific Consortium Publish Data & New Recommendations for In Vitro Risk Assessment of the Cardiac Safety of New Medicines
Metrion Biosciences Limited announced it has contributed to two new peer-reviewed papers under the US FDA CiPA (Comprehensive in vitro Proarrhythmia Assay) initiative. The papers,…
Novavax Identifies COVID-19 Vaccine Candidate; Accelerates Initiation of First-in-Human Trial to Mid-May
Novavax, Inc. recently announced it has identified a coronavirus vaccine candidate, NVX-CoV2373, a stable, prefusion protein made using Novavax’ proprietary nanoparticle technology, and will initiate…
COVID-19 Therapeutics: Summary of Recently Published Clinical Study using Hydroxychloroquine
Hydroxychloroquine sulphate (Plaquenil) an analog of chloroquine has an established track record for treating malaria and has demonstrated in vitro activity against the SARS-CoV and therefore …..
SGS Digicomply Launches AI System to Find Answers on COVID-19 Within Research Articles
SGS Digicomply recently announced the launch of a new version of its software dedicated exclusively to the research community and focused on finding….
For a CDMO, Flexibility & Adaptability Are Key Attributes to Navigate the Evolving Healthcare Landscape
The healthcare landscape continues to change at a rapid pace. The strong growth in the number of complex drugs, new therapeutic approaches and technologies, pricing issues and….